TY - JOUR T1 - Symptoms of common mental disorders and adherence to antiretroviral therapy among adults living with HIV in rural Zimbabwe: a cross-sectional study JF - medRxiv DO - 10.1101/2021.05.22.21257636 SP - 2021.05.22.21257636 AU - Andreas D Haas AU - Cordelia Kunzekwenyika AU - Stefanie Hossmann AU - Josphat Manzero AU - Janneke H van Dijk AU - Ronald Manhibi AU - Ruth Verhey AU - Andreas Limacher AU - Per von Groote AU - Ethel Manda AU - Michael Hobbins AU - Dixon Chibanda AU - Matthias Egger AU - for IeDEA Southern Africa Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/25/2021.05.22.21257636.abstract N2 - Objectives To examine the proportion of people living with HIV who screen positive for common mental disorders (CMD) and the associations between CMD and self-reported adherence to antiretroviral therapy (ART).Setting Sixteen government-funded health facilities in the rural Bikita district of Zimbabwe.Design Cross-sectional survey.Participants HIV-positive non-pregnant adults, aged 18 years or older, who lived in Bikita district and had received ART for at least six months.Outcome measures The primary outcome was the proportion of participants screening positive for CMD defined as a Shona Symptoms Questionnaire (SSQ-14) score of 9 or greater. Secondary outcomes were the proportion of participants reporting suicidal ideation, perceptual symptoms, and suboptimal ART adherence and adjusted prevalence ratios (aPR) for factors associated with CMD, suicidal ideation, perceptual symptoms, and suboptimal ART adherence.Results Out of 3,480 adults, 18.8% (95% confidence interval [CI] 14.8-23.7) screened positive for CMD, 2.7% (95% CI 1.5-4.7) reported suicidal ideations, and 1.5% (95% 0.9-2.6) reported perceptual symptoms. Positive CMD screens were more common in women (adjusted prevalence ratio [aPR] 1.67, 95% CI 1.19-2.35) than in men and were more common in adults aged 40-49 years (aPR 1.47 95% CI 1.16-1.85) or aged 50-59 years (20.3%; aPR 1.51 95% CI 1.05-2.17) than in those 60 years or older. Positive CMD screen was associated with suboptimal adherence (aPR 1.53; 95% CI 1.37-1.70).Conclusions A substantial proportion of people living with HIV in rural Zimbabwe are affected by CMD. There is a need to integrate mental health services and HIV programs in rural Zimbabwe.Strengths and limitations of this studyInclusion of a large sample of people living with HIV recruited at 16 government-funded primary and secondary care facilities in a rural district of Zimbabwe.Use of a locally developed screening tool that showed good psychometric properties for detecting common mental disorders in Zimbabwe in HIV-positive urban populations.The screening tool was not validated for the rural setting, and the cutoff score was selected based on data from the urban setting.Adherence to antiretroviral therapy was self-reported.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialWe conducted a cross-sectional study at 16 health facilities in Bikita district to assess the eligibility of individuals for a cluster-randomised trial (FB-ART) on the effect of the Friendship Bench intervention [22] on ART outcomes and symptoms of CMD in people living with HIV. We registered the trial with ClinicalTrials.gov (NCT03704805).Funding StatementME obtained funding for the study. AH, JvD, ME, CK, DC, SH and AL wrote the study protocol. JM and RM assisted with fieldwork and data collection which was overseen by CK and JvD. SH and AH did central data monitoring. AH conducted statistical analysis. AL advised on statistical analysis. AH and wrote the first draft of the paper which was revised by CK, JvD, RV, AL, MH, DC, PvG and ME. All contributed to interpretation of the results, commented on previous versions of the manuscript and read and approved the final manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the ethics committees of the Medical Research Council of Zimbabwe (MRCZ), the Research Council of Zimbabwe (RCZ), and the Canton of Bern, Switzerland. Individuals provided verbal consent for eligibility screening and collection and analysis of screening data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData cannot be made available online because of legal and ethical restrictions. To request data, readers may contact IeDEA for consideration by filling out the online form available at https://www.iedea-sa.org/contact-us/ ER -